Palvella Therapeutics, Inc.
PVLA
$23.98
-$0.45-1.84%
| 09/30/2024 | 06/30/2024 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | -102.00% | 0.00% | -675.61% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 62.90% | 0.00% | 133.41% | ||
| Change in Net Operating Assets | 171.25% | 0.00% | -2,367.59% | ||
| Cash from Operations | -102.74% | 0.00% | 23.56% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -51.34% | 0.00% | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 61.11% | 0.00% | -- | ||
| Cash from Financing | -51.23% | 0.00% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -109.18% | 0.00% | 23.56% | ||
